Brief: BridgeBio Pharma Reports Attruby Product Revenue $146 Mln In Q4
12/01/2026 16:11
Jan 12 (Reuters) - BridgeBio Pharma Inc BBIO.O: BRIDGEBIO PHARMA INC - ATTRUBY PRODUCT REVENUE $146 MILLION IN Q4 Source text: ID:nGNX3gRPB4 Further company coverage: BBIO.O (((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on BridgeBio Pharma
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
BridgeBio rises on FDA priority review for dwarfism drug
Brief: Bridgebio Announces FDA Acceptance And Priority Review Of NDA For Oral Infigratinib For Children With Achondroplasia
Brief: Bbp-418 Demonstrates Potential To Be Disease Modifying Therapy, Restoring Cardiac And Disease Markers To Unaffected Levels